THRX Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Theseus Pharmaceuticals

Theseus Pharmaceuticals Announces Closing of Tender Offer

2 years ago - By: Kahn Swick & Foti, LLC

THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX

2 years ago - By: Theseus Pharmaceuticals

Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results

2 years ago - By: InvestorPlace - Mentions: LESL AIMD FREQ

Why Is Leslies (LESL) Stock Down 36% Today?

2 years ago - By: Benzinga

Analyst Expectations for Theseus Pharmaceuticals's Future

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra

2 years ago - By: Benzinga

Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash

2 years ago - By: Halper Sadeh LLC

THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders

2 years ago - By: Theseus Pharmaceuticals

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

2 years ago - By: Seeking Alpha

Theseus Pharma fires CEO and medical chief (NASDAQ:THRX)

2 years ago - By: InvestorPlace - Mentions: NIR NYXH MOBQ CRKN ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: Theseus Pharmaceuticals

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

2 years ago - By: InvestorPlace - Mentions: AIRE TCRT INVO HRYU ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

2 years ago - By: Seeking Alpha

Theseus Pharmaceuticals explores strategic options; cuts workforce by 72% (NASDAQ:THRX)

2 years ago - By: Theseus Pharmaceuticals

Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives

2 years ago - By: InvestorPlace - Mentions: PLUG LESL AIMD

THESEUS PHARMACEUTICALS INC (THRX) Stock News

THRX Latest News, Press Relases and Analysis

Theseus Pharmaceuticals Announces Closing of Tender Offer

THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX

Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results

Why Is Leslies (LESL) Stock Down 36% Today?

Analyst Expectations for Theseus Pharmaceuticals's Future

Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra

Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash

THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Theseus Pharma fires CEO and medical chief (NASDAQ:THRX)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Theseus Pharmaceuticals explores strategic options; cuts workforce by 72% (NASDAQ:THRX)

Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives

PLUG Stock Alert: Plug Power Pops on Analyst Upgrade